Arş. Gör. Sami UZUN

Yayın Ağı

Makaleler 21

1. The Optimal Management Strategy for IGA Nephropathy Patients With Different Clinical Presentations

Ozturk S., Sumnu A., EREN N., DİNÇER M. T., Uzun S., Suleymanova V., et al.

Nephrology , cilt.31, sa.3, 2026 (SCI-Expanded, Scopus)

2. Glycaemic control and complications in haemodialysis patients: The TURK-HEMODIAB Study

Gungor O., KORUCU B., Oguz E. G., EREN N., KARACA URAL Z., Dheir H., et al.

Clinical Kidney Journal , cilt.19, sa.1, 2026 (SCI-Expanded, Scopus)

3. Comparative Longitudinal Evaluation of Systemic Inflammatory Markers in Type 2 Diabetes Treated with Four Oral Antidiabetic Drug Classes

Yamak M., Çakır S., Uzun S., Cebeci E., Menken Ö., Ozturk S.

Journal of Clinical Medicine , cilt.15, sa.2, 2026 (SCI-Expanded, Scopus)

4. The role of complement C3 deposition in ANCA-associated glomerulonephritis: a registry-based study of clinical, histopathological, and prognostic insights

Uzun S., Gok Oguz E., YILDIZ A., DERİCİ Ü., Cankaya E., Sahin G., et al.

BMC Nephrology , cilt.26, sa.1, 2025 (SCI-Expanded)

5. Demographic, clinical and laboratory characteristics of adult-onset minimal change disease in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working Group

Aydin Z., Yilmaz M., Sipahioglu M., DERVİŞOĞLU E., Aydemir N., Uzun S., et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.55, sa.4, ss.975-982, 2023 (SCI-Expanded)

6. CHARACTERISTICS AND SURVIVAL RESULTS OF PERITONEAL DIALYSIS PATIENTS SUFFERING FROM COVID-19 IN TURKEY: A MULTICENTER NATIONAL STUDY

GÜRSU M., ÖZTÜRK S., Arici M., Sahin I., Bek S., Yilmaz M., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.37, 2022 (SCI-Expanded)

7. EVALUATION OF OUTCOMES OF PERITONEAL DIALYSIS PATIENTS IN THE POST-COVID-19 PERIOD: A NATIONAL MULTICENTER CASE-CONTROL STUDY FROM TURKEY

Ozturk S., Gursu M., Arici M., Sahin I., Eren N., Yilmaz M., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.37, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Role of Ankle-Brachial Index Measured with Simple Automated Blood Pressure Devices in Predicting the Postoperative Kidney Functions in Non-Cardiac Patients with Low Renal Risk

Sumnu A., Islamoglu Z., Karadag S., Uzun S., Cebeci E., Yigit N., et al.

TURKISH JOURNAL OF NEPHROLOGY , cilt.31, sa.1, ss.58-65, 2022 (ESCI)

9. Characteristics of primary glomerular diseases patients with hematuria in Turkey: the data from TSN-GOLD Working Group.

Sumnu A., TÜRKMEN K., Cebeci E., Turkmen A., EREN N., Seyahi N., et al.

International urology and nephrology , cilt.53, sa.5, ss.945-954, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

10. An Unusual Case of Acute Kidney Injury Due to Secondary Oxalate Nephropathy Caused by Herbal Medicine

Ozler T. E., Cebeci E., Ozluk Y., Uzun S., Ozkan O., Karadag S., et al.

TURKISH JOURNAL OF NEPHROLOGY , cilt.30, sa.2, ss.183-185, 2021 (ESCI)

11. Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19.

TURGUTALP K., Ozturk S., ARICI M., EREN N., Gorgulu N., Islam M., et al.

BMC nephrology , cilt.22, sa.1, ss.29, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

12. Cardiometabolic role of visfatin in patients on peritoneal dialysis

Akarsu O., Baysal O., Karadag S., Gursu M., Ozkan O., Uzun S., et al.

Turkish Journal of Nephrology , cilt.29, sa.4, ss.297-303, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

13. Case report of a patient with Goodpasture’s syndrome who relapsed while on hemodialysis

Senel T. E., Uzun S., Cebeci E., Ozkan O., Behlul A., Eroglu A., et al.

Turkish Journal of Nephrology , cilt.28, sa.1, ss.88-90, 2019 (SCI-Expanded)

14. Flow-mediated dilatation and asymmetric dimethylarginine do not predict mortality in peritoneal dialysis patients Akım aracılı dilatasyon ve asimetrik dimetilargi periton diyalizi hastalarında mortalite prediktörü değildir

Uzun S., Karadag S., GÜRSU M., Cebeci E., Gurdal A., Senel T. E., et al.

Haseki Tip Bulteni , cilt.55, sa.3, ss.187-193, 2017 (Scopus) Sürdürülebilir Kalkınma

15. The role of midkine in the inflammatory process and its correlation with other inflammatory markers in renal transplant recipients.

Uzun S., Kaya B., Celik K., Behlul A., Ozkan O., Kuvvet M., et al.

The International journal of artificial organs , cilt.39, sa.6, ss.277-81, 2016 (SCI-Expanded)

16. Anthropometric measurements in hemodialysis patients Hemodiyaliz hastalarinda antropometrik ölçümler

Aydin Z., Sevim Y., Doner B., Gursu M., Karadag S., Uzun S., et al.

Turkish Nephrology, Dialysis and Transplantation Journal , cilt.24, sa.1, ss.61-67, 2015 (Scopus) Sürdürülebilir Kalkınma

17. Colistin nephrotoxicity increases with age

Balkan I. I., Dogan M., DURDU B., Batirel A., Hakyemez I. N., Cetin B., et al.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES , cilt.46, sa.10, ss.678-685, 2014 (SCI-Expanded)

18. The relationship between apelin and cardiac parameters in patients on peritoneal dialysis: Is there a new cardiac marker?

Karadag S., Ozturk S., Gursu M., Gurdal A., Basinoglu F., Yigit S., et al.

BMC Nephrology , cilt.15, sa.1, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

19. The relationship of plasma ADMA levels with cardiac functions and metabolic parameters in peritoneal dialysis patients

Ozturk S., Karadag S., Yegen M., Gursu M., Uzun S., Aydin Z., et al.

Clinical and Experimental Nephrology , cilt.17, sa.3, ss.431-436, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

20. The effect of different doses and types of intravenous iron on oxidative stress and inflammation in hemodialysis patients

Kumbasar A., Gursu M., Kaya C., Ozturk S., Ergen A., Kemik A., et al.

Journal of Nephrology , cilt.25, sa.5, ss.825-832, 2012 (SCI-Expanded)

21. Primary hyperoxaluria in an adult presenting with end-stage renal failure together with hypercalcemia and hypothyroidism

Karadag S., Gursu M., Aydin Z., Uzun S., Dogan O., Ozturk S., et al.

Hemodialysis International , cilt.15, sa.4, ss.573-576, 2011 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 4

1. THE EFFECT OF GLOMERULAR C3 DEPOSITION ON RENAL OUTCOME IN PATIENTS WITH MEMBRANOUS NEPHROPATHY: DATA OF THE TSN-GOLD STUDY

GÜRSU M., Ceheci E., Turkmen A., DERVİŞOĞLU E., Sezen M., TURGUTALP K., et al.

60th ERA Congress, Milan, İtalya, 15 - 18 Haziran 2023, (Özet Bildiri)

2. CHARACTERISTICS AND SURVIVAL DATA OF PATIENTS WITH PRIMARY FOCAL SEGMENTAL SEGMENTAL GLOMERULOSCLEROSIS: TSN-GOLDMULTI-CENTER STUDY

DHEİR H., Cebeci E., Karadag S., Yildiz A., Guller N., ALTIPARMAK M. R., et al.

60th ERA Congress, Milan, İtalya, 15 - 18 Haziran 2023, (Özet Bildiri)

3. CHARACTERISTICS OF PRIMARY GLOMERULAR DISEASE PATIENTS WITH HEMATURIA IN TURKEY: THE DATA FROM TSN-GOLD WORKING GROUP

Sumnu A., TÜRKMEN K., Cebeci E., Turkmen A., EREN N., Seyahi N., et al.

57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 Haziran 2020, cilt.35, ss.757, (Özet Bildiri)

4. ADULT MINIMAL CHANGE DISEASE IN TURKEY: THE RESULTS OF TURKISH SOCIETY OF NEPHROLOGY GLOMERULAR DISEASES WORKING GROUP

Yilmaz M., Sipahioglu M., DERVİŞOĞLU E., Aydemir N., Uzun S., Istemihan Z., et al.

57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 Haziran 2020, cilt.35, ss.768, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

109

H-İndeks (WoS)

Atıf (Scopus)

118

H-İndeks (Scopus)

BM Sürdürülebilir Kalkınma Amaçları